Compare HBB & CMPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HBB | CMPS |
|---|---|---|
| Founded | 1904 | 2020 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 251.2M | 724.5M |
| IPO Year | 2017 | 2020 |
| Metric | HBB | CMPS |
|---|---|---|
| Price | $20.94 | $5.65 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $26.57 |
| AVG Volume (30 Days) | 18.7K | ★ 1.9M |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.31% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.95 | N/A |
| Revenue | ★ $606,852,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $10.64 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $12.72 | $2.25 |
| 52 Week High | $20.98 | $8.90 |
| Indicator | HBB | CMPS |
|---|---|---|
| Relative Strength Index (RSI) | 66.23 | 44.12 |
| Support Level | $17.95 | $4.90 |
| Resistance Level | N/A | $7.02 |
| Average True Range (ATR) | 0.88 | 0.31 |
| MACD | 0.39 | 0.05 |
| Stochastic Oscillator | 90.62 | 77.87 |
Hamilton Beach Brands Holding Co, through its subsidiaries, is engaged in consumer, commercial, and specialty small appliances and specialty retail. It designs, markets, and distributes small branded electric household and specialty housewares small appliances, as well as commercial products for restaurants, bars, and hotels. It has two operating segments Home and Commercial Products segment includes consumer product revenue consisting of sales of small electric household and specialty housewares appliances whereas the health segment includes lease revenue associated with leases of connected devices to specialty pharmacy networks and pharmaceutical companies, as well as licensing revenue which grant customers the right to use software for healthcare management.
Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The company is conducting clinical trials to evaluate the safety and efficacy of this treatment in patients with treatment-resistant depression and other mental health disorders. The company operates in one operating segment.